Nordion Inc
(NYSE: NDZ)
+0.67
+9.41%
| Exchange: | NYSE |
| Stock: | Nordion Inc(USA) |
| Industry: | Medical Laboratories & Research |
| Employees: | 500 |
| Nordion Inc. (Nordion)is a global health science company, engaged providing products and services used for the prevention, diagnosis and treatment of disease. The Company’s operations are organized into three business segments: Targeted Therapies, Sterilization Technologies and Medical Isotopes as well as certain corporate functions and activities reported as Corporate and Other. The Company’s Targeted Therapies segment is focused on the targeted treatment of cancer. The Company’s Medical Isotopes segment primarily focuses on products used in the diagnosis and treatment of diseases, including cardiac and neurological conditions, and several types of cancer. The Company’s shared corporate functions and activities are reported as Corporate and Other. The Company has two business units Targeted Therapies and Specialty Isotopes. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
